How agri-biotech contributes to the EU bio...In October 2012, the European Commission issued a communication on its new Industrial policy identifying biotechnology as one of six Key Enabling Technologies. Biotech will be an important tool in helping … more ➔
Resistance spurs revival of antibiotics in...When penicillin was discovered by Dr. Alexander Fleming in 1928, people around the world believed it was one of the greatest medical and scientific advances in the history of mankind and they were right. … more ➔
The trinity that’s given me back som...I am spoiled for choice this month on things that make me happy about biotech. Three things have happened across Europe that confirm the field has great people that work hard, recognise the truth when … more ➔
Striking a balance in greater clinical tri...In the past year, the debate surrounding increased transparency of clinical trials has seen a great deal of progress. From an industry perspective, we have engaged more openly with a greater diversity … more ➔
Don’t mess with nature just ride th...Welcome to December, and a rather nautical analogy this month. I don’t mean the title of this piece literally of course messing with nature is what biotech is supposed to do (in a well thought-out and … more ➔
Why Europe needs a European Biotech WeekPut simply, biotechnology is the use of living organisms to develop useful products. Its basic principles have been employed to alter plants and livestock for domestication for thousands of years. more ➔
It’s all about recognising your targ...Hurrah for the news that a GM yeast has been developed that can convert crop waste into biofuel! Not just because this is an awesome thing in its own right (which it is), but also because it opens up … more ➔
Shifting paradigms in EU biotechnology pol...The start of Europe’s new financial framework and the framework research programme Horizon 2020 seems a good moment to take a step back and look into some recent and not so recent – but even more substantial … more ➔
Will regulation finally pay off for Europe...A recent interesting look at markets beyond Europe has given some interesting food for thought. You know, sometimes the EU is actually easier to do business in than many other places. Sounds a bit crazy, … more ➔
Carsten Thiel: In biosimilars, don’t...Biosimilar products are not generic medicines, nor are they identical to their reference product or each other. Instead, they are similar versions of well-established recombinant proteins with well-characterised … more ➔
